|
WO2021078912A1
|
|
Treatment of non-alcoholic fatty liver disease
|
|
WO2021032650A1
|
|
Peptides for treating muscle atrophy
|
|
EP3783012A1
|
|
An antimicrobial peptide
|
|
CN110381976A
|
|
Composition including peptide WKDEAGKPLVK
|
|
EP3329930A1
|
|
Pharmaceuctical compositions
|
|
EP3329905A1
|
|
Topical cosmetic compositions comprising an oligopeptide against anti-aging of the skin
|
|
US2017183386A1
|
|
Peptides, and uses thereof
|
|
BR112018000660A2
|
|
anti-inflammatory peptides and their use
|
|
WO2018014936A1
|
|
Topical compositions
|
|
EP3118216A1
|
|
Cellular growth and proliferation promoting peptides, and uses thereof
|
|
EP3118215A1
|
|
Anti-inflammatory peptides, and uses thereof
|
|
EP3117831A1
|
|
Peptides for use in promoting transport of glucose into skeletal muscle
|
|
EP3117830A1
|
|
Antibacterial peptides, and uses thereof
|
